About: Emergence of drug resistance in HIV type 1-infected patients after receipt of first-line highly active antiretroviral therapy: a systematic review of clinical trials

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Emergence of drug resistance in HIV type 1-infected patients after receipt of first-line highly active antiretroviral therapy: a systematic review of clinical trials Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on September 2008

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) article scientifique (fr) artículu científicu espublizáu en 2008 (ast) наукова стаття, опублікована у вересні 2008 (uk) مقالة علمية نشرت في سبتمبر 2008 (ar) scientific article published on September 2008 (en)
publication date	wds:Q37228748-BEE52B0A-B837-4457-AEBB-D4994A8FE62C
publication date	2008-09-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q37228748-9F15875F-F01F-41EC-9050-8B65A8C15185
language of work or name	English
cites work	wds:Q37228748-06DC4668-2157-4C4C-8003-A5A66DAF0BF9 wds:Q37228748-0F3DB7B5-6E8B-4DAE-BD48-94A9CB35C80A wds:Q37228748-13F8820F-C68C-4066-A86D-39C2FDE74EE6 wds:Q37228748-458B8F80-528E-4393-8744-9E5711ABEDE4 wds:Q37228748-5229A2E5-B646-4F67-B6D4-4FDDEF3CD46D wds:Q37228748-522B3305-761F-44D1-8AF4-247C81FA8B09 wds:Q37228748-56F21782-9A55-4DE0-80A3-BB94257BDFE7 wds:Q37228748-58CB62C9-026E-4B6F-A1F2-EDFF1D0826B7 wds:Q37228748-6C3DDC63-74DB-4159-B691-B794945D7E3A wds:Q37228748-73821C55-0642-4A6E-8F8B-070AA9DA4A2A wds:Q37228748-8D18BC7D-1393-44F4-9BD3-FEC96D744970 wds:Q37228748-8D55248F-277C-47C7-A0D4-1B6E09DBA5C0 wds:Q37228748-97AF20A7-ECDB-40C3-AC84-1C972A7AE241 wds:Q37228748-A4998E6E-305B-445E-BF21-2FE25960DCFB wds:Q37228748-AC68E5FA-D09F-42B3-B393-8BFE2EC03185 wds:Q37228748-B17A032E-326F-4C44-B087-3653CB3190FA wds:Q37228748-C745A1D4-7FE6-4B30-B89A-BAFA673752BC wds:Q37228748-CD8301FB-2925-42B1-8012-699D7FEC3B77 wds:Q37228748-CF214AE8-4B60-4C9E-A3F4-22D6F6CC60F0 wds:Q37228748-D66716E1-DD01-46C8-8CB7-CFE332EFC9E4 wds:Q37228748-D86D873C-976D-47B5-BE0D-95A6B0098162 wds:Q37228748-E50024AE-9CD5-45D5-8721-AC8F95470293 wds:Q37228748-E6FE1D3F-BBB2-4955-92D6-CC053A07AB79
cites work	Emergence of minor populations of human immunodeficiency virus type 1 carrying the M184V and L90M mutations in subjects undergoing structured treatment interruptions Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV. Lopinavir-ritonavir versus nelfinavir for the initial treatment of HIV infection. Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel. Once-daily versus twice-daily lamivudine, in combination with zidovudine and efavirenz, for the treatment of antiretroviral-naive adults with HIV infection: a randomized equivalence trial Incidence of resistance in a double-blind study comparing lopinavir/ritonavir plus stavudine and lamivudine to nelfinavir plus stavudine and lamivudine The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial Long-term (120-Week) antiviral efficacy and tolerability of fosamprenavir/ritonavir once daily in therapy-naive patients with HIV-1 infection: an uncontrolled, open-label, single-arm follow-on study SOLO: 48-week efficacy and safety comparison of once-daily fosamprenavir /ritonavir versus twice-daily nelfinavir in naive HIV-1-infected patients Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types Abacavir versus zidovudine combined with lamivudine and efavirenz, for the treatment of antiretroviral-naive HIV-infected adults Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment. Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study Role of minority populations of human immunodeficiency virus type 1 in the evolution of viral resistance to protease inhibitors. Predictors of long-term viral failure among ugandan children and adults treated with antiretroviral therapy The global status of resistance to antiretroviral drugs Abacavir once or twice daily combined with once-daily lamivudine and efavirenz for the treatment of antiretroviral-naive HIV-infected adults: results of the Ziagen Once Daily in Antiretroviral Combination Study. Detection of minor populations of drug-resistant HIV-1 in acute seroconverters. Clinical and immunogenetic correlates of abacavir hypersensitivity GW433908/ritonavir once daily in antiretroviral therapy-naive HIV-infected patients: absence of protease resistance at 48 weeks Genotype and phenotype at baseline and at failure in human immunodeficiency virus-infected antiretroviral-naive patients in a randomized trial comparing zidovudine and lamivudine plus nelfinavir or nevirapine
author name string	wds:Q37228748-0C779D4E-0B4D-4234-82C7-824C151E6B8A wds:Q37228748-2F2329BC-4E55-4F6F-BDF3-34C3DA36D281 wds:Q37228748-B914D760-3FF2-4FB5-AA63-15F99B41279A
author name string	Andrew Hill Ravindra Gupta Anthony W Sawyer
rdfs:label	Emergence of drug resistance in HIV type 1-infected patients after receipt of first-line highly active antiretroviral therapy: a systematic review of clinical trials (en) Emergence of drug resistance in HIV type 1-infected patients after receipt of first-line highly active antiretroviral therapy: a systematic review of clinical trials (nl) Emergence of drug resistance in HIV type 1-infected patients after receipt of first-line highly active antiretroviral therapy: a systematic review of clinical trials (ast)
skos:prefLabel	Emergence of drug resistance in HIV type 1-infected patients after receipt of first-line highly active antiretroviral therapy: a systematic review of clinical trials (en) Emergence of drug resistance in HIV type 1-infected patients after receipt of first-line highly active antiretroviral therapy: a systematic review of clinical trials (nl) Emergence of drug resistance in HIV type 1-infected patients after receipt of first-line highly active antiretroviral therapy: a systematic review of clinical trials (ast)
name	Emergence of drug resistance in HIV type 1-infected patients after receipt of first-line highly active antiretroviral therapy: a systematic review of clinical trials (en) Emergence of drug resistance in HIV type 1-infected patients after receipt of first-line highly active antiretroviral therapy: a systematic review of clinical trials (nl) Emergence of drug resistance in HIV type 1-infected patients after receipt of first-line highly active antiretroviral therapy: a systematic review of clinical trials (ast)
author	wds:Q37228748-07B702DF-3481-4109-90E2-46FD272178CF
author	Deenan Pillay
title	wds:Q37228748-59CA80AD-B9F6-4333-BD04-468E2D9C8496
title	Emergence of drug resistance in HIV type 1-infected patients after receipt of first-line highly active antiretroviral therapy: a systematic review of clinical trials (en)
page(s)	wds:Q37228748-4FBDFC1D-4764-4DFB-8374-2AE820ADBC53
page(s)	712-722
instance of	wds:Q37228748-077915FB-7879-4CAA-AC18-F4D08A90BAE4 wds:Q37228748-58147129-4ff0-474c-ade6-c1eb0ad07433
instance of	meta-analysis scholarly article
main subject	wds:Q37228748-03163BC4-6580-44BF-AAE0-691F5CD4F5C1 wds:Q37228748-0C2205DE-0057-4D29-B208-26EDFCC10F13 wds:Q37228748-3822FA6F-2518-4280-9E8A-D927E9787568 wds:Q37228748-B1805B17-EFED-4B5C-964A-67FBB5A98E73 wds:Q37228748-ED462FFC-C513-4465-8798-968CADD1795E
main subject	HIV Patients systematic review

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software